State Street Corporation 13D and 13G filings for Syndax Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-18 11:49 am Sale |
2024-09-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
STATE STREET CORP STT |
3,770,826 4.400% |
-1,245,398 (-24.83%) |
Filing |
| 2024-01-25 11:20 am Purchase |
2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
STATE STREET CORP STT |
5,016,224 5.910% |
1,367,761 (+37.49%) |
Filing |
| 2023-02-06 2:46 pm Purchase |
2022-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
STATE STREET CORP STT |
3,648,463 5.360% |
3,648,463 (New Position) |
Filing |